GSTS Pathology Innovation Academy Demonstrates the Impact of Personalized Medicine
News Dec 18, 2013
The second Innovation Academy hosted by GSTS Pathology, attracted more than 100 delegates to the Royal Institution of Great Britain on Friday 6th December 2013.
The theme of the symposium - ‘Personalized medicine: today’s reality, not just a promise for tomorrow’, examined advances in three areas - therapeutic drug monitoring, infectious diseases and transplantation, and oncology - with particular recognition of the impact personalized medicine is making in healthcare.
For more than 200 years the Royal Institution of GB has been home to eminent scientists whose discoveries have helped to shape the modern world, making it a particularly inspiring venue for this Innovation Academy event. Speakers included respected scientists and clinicians from across healthcare, industry and GSTS Pathology.
The Innovation Academy aims to support and showcase scientific innovations developed at GSTS and how they can improve patient care now and in the future.
Fiona Carragher, Deputy Chief Scientific Officer for England, opened the meeting by discussing the many challenges facing today’s heath service and how they can be addressed. “Science will be crucial in this, with research constantly informing new ways of working. While personalized medicine has been in use for a long time - for example INR measurement in anticoagulation therapy - it is clear that genomics and personalized medicine continue to be at the forefront of many new techniques.”
Dr Dominic Harrington, Scientific Director, GSTS Pathology, co-organized the symposium. “Personalized medicine isn’t just a theoretical research idea, but offers practical solutions for tailoring and monitoring therapies in a wide variety of clinical conditions, delivering improvements in patient care today. The Innovation Academy aims to create an environment supportive of innovation, quality and the development of our future scientific leaders. We know that good science equals good medicine.”
As the UK’s leading independent provider of pathology services, GSTS Pathology LLP provides a full suite of clinically led pathology services that make a real difference to patient care.
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE
Inflammatory Biomarkers Indicating Brain Injury IdentifiedNews
Researchers at the University of Birmingham have identified inflammatory biomarkers which indicate whether the brain has suffered injury. It is hoped that the biomarkers could be used to develop a diagnostic test to rapidly detect brain injury at the scene of an incident.READ MORE